Full text loading...
No data available.
Please log in to see this content.
You have no subscription access to this content.
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
Dosimetry for ocular proton beam therapy at the Harvard Cyclotron Laboratory based on the ICRU Report 59
1.H. B. Stallard, “Malignant melanoblastoma of the choriod,” Mod. Probl. Ophthalmol. 7, 16–38 (1966).
2.J. L. Hungerford, A. J. E. Foss, I. Whelahan, R. D. Errington, A. Kacperek, and J. Kongerud, “Side effects of photon and proton radiotherapy for ocular melanoma,” in Radiotherapy of Ocular Disease. Frontiers in Radiation Therapy and Oncology, edited by T. Wiegel, N. Bornfeld, M. H. Foerster, and W. Hinkelbein (Karger, Basil, 1997), pp. 287–293.
3.E. S. Gragoudas, A. M. Lane, S. Regan, W. Li, H. E. Judge, J. E. Munzenrider, J. M. Seddon, and K. M. Egan, “A randomized controlled trial of varying radiation doses in the treatment of choroidal melanoma,” Arch. Ophthalmol. (Chicago) 118, 773–778 (2000).
4.J. E. Munzenrider, “Uveal melanomas: Conservation treatment,” Hematol. Oncol. Clin. North Am. 15, 389–402 (2001).
5.M. Fuss, L. N. Loredo, P. A. Blancharski, R. I. Grove, and J. D. Slater, “Proton radiation therapy for medium and large choroidal melanoma: Preservation of the eye and its functionality,” Int. J. Radiat. Oncol., Biol., Phys. 49, 1053–1059 (2001).
6.I. J. Constable and A. M. Koehler, “Experimental ocular irradiation with accelerated protons,” Invest. Ophthalmol. 13, 280–287 (1974).
7.E. S. Gragoudas, M. Goitein, L. Verhey, J. Munzenrider, H. Suit, and A. Koehler, “Proton beam irradiation: An alternative to enucleation for intraocular melanomas,” Ophthalmology (Philadelphia) 87, 571–581 (1980).
8.J. E. Munzenrider, L. J. Verhey, E. S. Gragoudas, J. M. Seddon, M. Urie, R. Gentry, S. Birnbaum, D. Ruotolo, C. Crowell, P. McManus, S. Finn, J. Sisterson, K. Johnson, K. Egan, D. Lento, and P. Bassin, “Conservative treatment of uveal melanoma: Local recurrence after proton beam therapy,” Int. J. Radiat. Oncol., Biol., Phys. 17, 493–498 (1989).
9.E. S. Gragoudas, K. M. Egan, S. M. Walsh, S. Regan, J. E. Munzenrider, and V. Taratuta, “Lens changes after proton beam irradiation for uveal melanoma,” Am. J. Opthalmol. 119, 157–164 (1995).
10.D. H. Char, W. Saunders, J. R. Castro, J. M. Quivey, A. R. Irvine, R. D. Stone, J. B. Crawford, M. Barricks, L. I. Lonn, G. F. Hilton, A. Schwartz, G. T. Y. Chen, J. T. Lyman, M. Collier, H. Sulit, B. Straatsma, and A. Kaminski, “Helium ion therapy for choroidal melanoma,” Ophthalmology (Philadelphia) 90, 1219–1225 (1983).
11.M. W. Wilson, J. L. Hungerford, and D. Fuller, “Comparison of episcleral plaque and proton beam radiation therapy for the treatment of choroidal melanoma,” Ophthalmology (Philadelphia) 106, 1579–1587 (1999).
12.H. D. Suit, M. Krengli, and J. E. Munzenrider, “Clinical experience with proton beam therapy at MGH/HCL: Proton Radiation Oncology Group trials,” in Advances in Hadrontherapy, Proceedings of the International Week on Hadrontherapy, Archamps, France, 20–24 November 1995, edited by U. Amaldi, B. Larsson, and Y. Lemoigne (Elsevier, Amsterdam, 1997), pp. 103–110.
13.L. T. Yonemoto, J. D. Slater, E. J. Friedrichsen, L. N. Loredo, J. Ing, J. O. Archambeau, S. Teichman, M. F. Moyers, P. A. Blacharski, and J. M. Slater, “Phase I/II study of proton beam irradiation for the treatment of subfoveal choroidal neovascularization in age-related macular degeneration: Treatment techniques and preliminary results,” Int. J. Radiat. Oncol., Biol., Phys. 36, 867–871 (1996).
14.J. O. Archambeau, X. W. Mao, L. T. Yonemoto, J. D. Slater, E. Friedrichsen, S. Teichman, W. Preston, and J. M. Slater, “What is the role of radiation in the treatment of subfoveal membranes: Review of radiobiologic, pathologic, and other considerations to initiate a multimodality discussion,” Int. J. Radiat. Oncol., Biol., Phys. 40, 1125–1136 (1998).
15.J. A. Adams, K. L. Paiva, J. E. Munzenrider, J. W. Miller, and E. S. Gragoudas, “Proton beam therapy for age-related macular degeneration: Development of a standard plan,” Med. Dosim 24, 233–238 (1999).
16.M. F. Moyers, R. A. Galindo, L. T. Yonemoto, L. Loredo, E. J. Friedrichsen, M. A. Kirby, J. D. Slater, and J. M. Slater, “Treatment of macular degeneration with proton beams,” Med. Phys. 26, 777–782 (1999).
17.J. M. Sisterson, “Ion beam therapy: Overview of the world experience,” in Proceedings of the 16th International Conference on Accelerators in Research Physics, edited by J. L. Duggan and I. L. Morgan, (American Institute of Physics, New York, 2001), pp. 865–868.
18.A. Smith, R. Hilco, J. Dicello, P. Fessenden, M. Henkelman, K. Hogstrom, G. Lam, J. Lyman, H. Blattman, M. Salsmann, D. Reading, and L. Verhey, “Dosimetry intercomparison between heavy charged particle radiotherapy facilities,” Pion and Heavy Particle Radiotherapy: Pre-Clinical and Clinical Studies, edited by L. Skarsgard, 1982, pp. 49–60.
19.S. Vatnitsky, J. Siebers, D. Miller, M. Moyers, M. Schaefer, D. Jones, S. Vynckier, Y. Hayakawa, S. Delacroix, U. Isacsson, J. Medin, A. Kacperek, A. Lomax, A. Coray, H. Kluge, J. Heese, L. Verhey, I. Daftari, K. Gall, G. Lam, T. Beck, and G. Hartmann, “Proton dosimetry intercomparison,” Radiother. Oncol. 41, 169–177 (1996).
20.S. Delacroix, A. Bridier, A. Mazal, J. Daures, A. Ostrowsky, C. Nauraye, A. Kacperek, S. Vynkier, N. Brassard, and J.-L. Habrand, “Proton dosimetry comparison involving ionometry and calorimetry,” Int. J. Radiat. Oncol., Biol., Phys. 37, 711–718 (1997).
21.W. Newhauser, A. Smith, J. Burns, K. Gall, C. Mayo, S. Rosenthal, and M. Wagner, “A report on the change in the proton absorbed dose measurement protocol for the clinical trials conducted at the Harvard Cyclotron Laboratory,” Med. Phys. 25, A144–A145 (1998).
22.W. D. Newhauser, A. R. Smith, J. Beatty, and J. A. Micka, “Proton beam dosimetry. I. Determination of air-filled ionization chamber calibration coefficients in radiation,” Northeast Proton Therapy Center Report No. NPTC-HD-101, 28 August 2000.
23.W. D. Newhauser and A. R. Smith, “Proton beam dosimetry. II. Calculation of values for air-filled ionization chambers at 100-MeV proton beam energy,” Northeast Proton Therapy Center Report No. NPTC-HD-105, 18 September 2000.
24.W. D. Newhauser and A. R. Smith, “Proton beam dosimetry. III. Comparison of absorbed dose determinations in the large-field beam of the Harvard Cyclotron Laboratory based on Faraday cup and ionization chamber methods,” Northeast Proton Therapy Center Report No. NPTC-HD-108, 22 December 2000.
25.A. M. Koehler, “Dosimetry of proton beams using small silicon diodes,” Radiat. Res., Suppl. 7, 53–63 (1967).
26.W. M. Preston and A. M. Koehler, “Proton beam dosimetry,” Harvard University, Department of Physics Internal Report, Cambridge, December 1965.
27.L. J. Verhey, A. M. Koehler, J. C. McDonald, M. Goitein, I.-Chang Ma, R. J. Schneider, and M. Wagner, “The determination of absorbed dose in a proton beam for purposes of charged-particle radiation therapy,” Radiat. Res. 79, 35–54 (1979).
28.J. T. Lyman, M. Awschalom, P. Berardo, H. Bichsel, G. T. Y. Chen, J. Dicello, P. Fessenden, M. Goitein, G. Lam, J. C. McDonald, A. R. Smith, R. T. Haken, L. Verhey, and S. Zink, “Protocol for heavy charged particle therapy beam dosimetry,” Report No. 16, American Association of Physicists in Medicine, American Institute of Physics, New York, 1986.
29.S. Vynckier, D. E. Bonnett, and D. L. T. Jones, “Code of practice for clinical proton dosimetry,” Radiother. Oncol. 20, 53–63 (1991).
30.“Clinical proton dosimetry. I. Beam production, beam delivery, and measurement of absorbed dose,” ICRU Report No. 59, International Commission on Radiation and Units, Bethesda, 1998.
31.International Atomic Energy Agency, “Absorbed dose determination in external beam radiotherapy: An international code of practice for dosimetry based on standards of absorbed dose to water, ” Technical Report Series No. 398, IAEA, Vienna, 2001.
32.X. Yan, U. Titt, A. M. Koehler, and W. D. Newhauser, “Measurement of neutron dose equivalent to proton therapy patients outside of the proton radiation field,” Nucl. Instrum. Methods (in press).
33.Ionization chamber calibration report No. EQC0025 (Exradin Model T1, serial No. 233), University of Wisconsin–Madison, Accredited Dosimetry Calibration Laboratory, 6 March 1998.
34.M. Boutillion, “Comite Consultatif des les Etalons de Mesure des Rayonnements Ionisants, Offilib. Values of g for photon energies,” 85-18, Bureau International des Poids et Mesures, Sevres, 1987.
35.J. B. Smathers, V. A. Otto, A. R. Smith, P. R. Almond, F. H. Attix, J. J. Spokas, W. M. Quam, and L. J. Goodman, “Composition of A-150 tissue equivalent plastic,” Med. Phys. 4, 74–77 (1975).
36.W. D. Newhauser, K. D. Myers, S. Rosenthal, and A. R. Smith, “Proton beam dosimetry. IV. Absorbed dose determinations in the radiosurgery beam of the Harvard Cyclotron Laboratory based on ionization chamber measurements and ICRU Report 59,” Northeast Proton Therapy Center Report No. NPTC-HD-111, 9 April 2001. [A shortened version of this report appears in Phys. Med. Biol. 47, 1369–1389 (2002)].
37.P. L. Petti, “A measurement of w, the energy required to create an ion pair, for 150 MeV protons in nitrogen and argon, ” Ph.D. thesis, Harvard University, Cambridge, 1985.
38.C. Mayo, “Faraday cup dosimetry at the Harvard Cyclotron Laboratory,” Harvard Cyclotron Laboratory internal report, Cambridge (undated).
39.C. Mayo, J. M. Sisterson, M. Wagner, B. Gottschalk, and A. M. Koehler, “Faraday cup dosimetry in proton beam therapy,” Med. Phys. 18, 625 (abstract) (1991).
40.C. Mayo, “Summary of calibration parameters,” Internal Report, Harvard Cyclotron Laboratory, Cambridge, 6 April 1993.
41.A. M. Koehler (private communication).
42.J. F. Janni, “Proton range-energy tables. I, II,” At. Data Nucl. Data Tables 27, 147–529 (1982).
43.S. Vatnitsky, M. Moyers, D. Miller, G. Abell, E. Pedroni, A. Coray, A. Mazal, W. Newhauser, O. Jaekel, J. Heese, A. Fukumura, Y. Futami, L. Verhey, I. Daftari, E. Grusell, A. Molokanov, and C. Bloch, “Proton dosimetry intercomparison based on the ICRU 59 protocol,” Radiother. Oncol. 51, 273–279 (1999).
44.J. W. Mueller, “Weighted medians,” Bureau International des Poids et Mesures, BIPM Report No. 2000/6, Sevres, 2000.
45.J. Medin, P. Andreo, and S. Vynckier, “Comparison of dosimetry recommendations for clinical proton beams,” Phys. Med. Biol. 45, 3195–211 (2000).
46.L. J. Verhey, “Response to ‘Comparison of dosimetry recommendations for clinical proton beams,’ ” Phys. Med. Biol. 45, L51–L52 (2000).
47.P. Andreo, J. Medin, and S. Vynckier, “Reply to the comments of L. J. Verhey on ‘Comparison of dosimetry recommendations for clinical proton beams,’ ” Phys. Med. Biol. 45, L52–L54 (2000).
48.E. Grusell, U. Isacsson, A. Montelius, and J. Medin, “Faraday cup dosimetry in a proton therapy beam without collimation,” Phys. Med. Biol. 40, 18 31 (1995).
49.J. F. Ziegler, P. A. Saunders, and T. H. Zabel, “Portable Faraday cup for nonvacuum proton beams,” IBM J. Res. Dev. 40, 73–76 (1996).
50.R. Cambria, J. Herault, N. Brassart, M. Silari, and P. Chauvel, “Proton beam dosimetry: A comparison between the Faraday cup and an ionization chamber,” Phys. Med. Biol. 42, 1185–1196 (1997).
51.J. Medin and P. Andreo, “Monte Carlo calculated stopping-power ratios, water/air, for clinical proton dosimetry (50–250 MeV),” Phys. Med. Biol. 42, 89–105 (1997).
52.Thimble ionization chamber model T1 specifications and usage instructions. Exradin Inc., Lisle, IL, 2000.
Article metrics loading...